Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Martinelli

Showing results (1-10 of 657) with videos related to

Pageof 66
Sort By:
Oncotarget|December 8, 2017
Blinatumomab in Ph+ B-ALL: present and perspectivesCristina Papayannidis, Giovanni Martinelli
Minerva Medica|September 22, 2020
Acute leukemias in 2020: state of the artClaudio Cerchione, Giovanni Martinelli
Panminerva Medica|September 22, 2020
Multiple myeloma in 2020: state of the artClaudio Cerchione, Giovanni Martinelli
The Lancet. Haematology|December 22, 2015
Interferon in CML: back to the past, or towards the future?Simona Soverini, Giovanni Martinelli
Sensors (Basel, Switzerland)|November 10, 2020
Accuracy of Mobile Applications versus Wearable Devices in Long-Term Step MeasurementsFilippo Piccinini, Giovanni Martinelli, Antonella Carbonaro
Bioinformatics (Oxford, England)|September 30, 2020
Colour deconvolution: stain unmixing in histological imagingGabriel Landini, Giovanni Martinelli, Filippo Piccinini
Hematology Reports|October 12, 2020
How I manage frontline transplant-eligible multiple myeloma in ItalyVittorio Montefusco, Giovanni Martinelli, Claudio Cerchione
Frontiers in Oncology|January 24, 2022
Hypomethylating Agent-Based Combination Therapies to Treat Post-Hematopoietic Stem Cell Transplant Relapse of Acute Myeloid LeukemiaGiulia Ciotti, Giovanni Marconi, Giovanni Martinelli
Hematology Reports|January 7, 2021
The molecular pathogenesis of multiple myelomaNiccolò Bolli, Giovanni Martinelli, Claudio Cerchione
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 15, 2021
Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myelomaClaudio Cerchione, Davide Nappi, Giovanni Martinelli
Pageof 66

Showing results (1-10 of 657) with videos related to

Sort By:
Pageof 66
Oncotarget|December 8, 2017
Blinatumomab in Ph+ B-ALL: present and perspectivesCristina Papayannidis, Giovanni Martinelli
Minerva Medica|September 22, 2020
Acute leukemias in 2020: state of the artClaudio Cerchione, Giovanni Martinelli
Panminerva Medica|September 22, 2020
Multiple myeloma in 2020: state of the artClaudio Cerchione, Giovanni Martinelli
The Lancet. Haematology|December 22, 2015
Interferon in CML: back to the past, or towards the future?Simona Soverini, Giovanni Martinelli
Sensors (Basel, Switzerland)|November 10, 2020
Accuracy of Mobile Applications versus Wearable Devices in Long-Term Step MeasurementsFilippo Piccinini, Giovanni Martinelli, Antonella Carbonaro
Bioinformatics (Oxford, England)|September 30, 2020
Colour deconvolution: stain unmixing in histological imagingGabriel Landini, Giovanni Martinelli, Filippo Piccinini
Hematology Reports|October 12, 2020
How I manage frontline transplant-eligible multiple myeloma in ItalyVittorio Montefusco, Giovanni Martinelli, Claudio Cerchione
Frontiers in Oncology|January 24, 2022
Hypomethylating Agent-Based Combination Therapies to Treat Post-Hematopoietic Stem Cell Transplant Relapse of Acute Myeloid LeukemiaGiulia Ciotti, Giovanni Marconi, Giovanni Martinelli
Hematology Reports|January 7, 2021
The molecular pathogenesis of multiple myelomaNiccolò Bolli, Giovanni Martinelli, Claudio Cerchione
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 15, 2021
Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myelomaClaudio Cerchione, Davide Nappi, Giovanni Martinelli
Pageof 66